Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tuberculous monoarthritis of the knee joint.
Gunton A, Losie J, Connors W. Gunton A, et al. Among authors: connors w. CMAJ. 2023 Jun 5;195(22):E782-E785. doi: 10.1503/cmaj.220838. CMAJ. 2023. PMID: 37277132 Free PMC article. No abstract available.
Real-life experience with IV dalbavancin in Canada; results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry.
Zhanel G, Silverman M, Malhotra J, Baxter M, Rahimi R, Irfan N, Girouard G, Dhami R, Kucey M, Stankus V, Schmidt K, Poulin S, Connors W, Tascini C, Walkty A, Karlowsky J. Zhanel G, et al. Among authors: connors w. J Glob Antimicrob Resist. 2024 Sep;38:154-157. doi: 10.1016/j.jgar.2024.06.002. Epub 2024 Jun 20. J Glob Antimicrob Resist. 2024. PMID: 38908823 Free article.
Monoarthrite tuberculeuse de l’articulation du genou.
Gunton A, Losie J, Connors W. Gunton A, et al. Among authors: connors w. CMAJ. 2023 Aug 21;195(32):E1086-E1090. doi: 10.1503/cmaj.220838-f. CMAJ. 2023. PMID: 37604525 Free PMC article. French. No abstract available.
Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease.
Haley CA, Schechter MC, Ashkin D, Peloquin CA, Peter Cegielski J, Andrino BB, Burgos M, Caloia LA, Chen L, Colon-Semidey A, DeSilva MB, Dhanireddy S, Dorman SE, Dworkin FF, Hammond-Epstein H, Easton AV, Gaensbauer JT, Ghassemieh B, Gomez ME, Horne D, Jasuja S, Jones BA, Kaplan LJ, Khan AE, Kracen E, Labuda S, Landers KM, Lardizabal AA, Lasley MT, Letzer DM, Lopes VK, Lubelchek RJ, Patricia Macias C, Mihalyov A, Misch EA, Murray JA, Narita M, Nilsen DM, Ninneman MJ, Ogawa L, Oladele A, Overman M, Ray SM, Ritger KA, Rowlinson MC, Sabuwala N, Schiller TM, Schwartz LE, Spitters C, Thomson DB, Tresgallo RR, Valois P, Goswami ND; BPaL Implementation Group. Haley CA, et al. Clin Infect Dis. 2023 Oct 5;77(7):1053-1062. doi: 10.1093/cid/ciad312. Clin Infect Dis. 2023. PMID: 37249079 Free PMC article.
42 results